- The document discusses first trimester screening (FTS), which involves an NT scan and serum biochemistry between 11-13.6 weeks of pregnancy.
- FTS allows for early prediction, prevention, diagnosis and management of complications like aneuploidies, preeclampsia, fetal growth restriction, and preterm birth.
- The NT scan measures nuchal translucency thickness, which is increased in fetuses with chromosomal abnormalities. Combined with blood tests, FTS can assess risk for conditions like Trisomy 21, 18, 13, preeclampsia and more.